| | | |  | | | | By Angus Chen Lynne Sladky/AP Being invited to have a colonoscopy did reduce colon cancer risk, but only by about the same amount as cheaper, less invasive tests. Read More | | Sponsor content by Olema Oncology Next Generation Endocrine Therapy for ER+/HER2- Breast Cancer: Not All SERDs are Created Equal Our understanding of the estrogen receptor (ER) signaling pathway and the resistance mechanisms that develop in metastatic breast cancer is evolving, and the search for a better ER antagonist has shown us the characteristics that would make up an ideal next generation complete ER antagonist (CERAN). Learn more about progress in developing new therapies for ER+ breast cancer. | | By Tara Bannow Adobe Florida-based American Oncology Network is going public via a SPAC, a year after another large oncology provider chain took the same route. Read More | | By M. Gregg Bloche and Neel U. Sukhatme and John L. Marshall Adobe The Inflation Reduction Act ties Medicare's payment for treatments to how well they work. That could catalyze biomedical breakthroughs. Read More | |
No comments